GlassScriptPhysician profile
Carrie A Downey
NPI 1396164042
$5,870.10
in general payments reported to CMS, 2019-2025
38 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $608 · 2020: $985 · 2021: $3,169 · 2022: $747 · 2023: $345 · 2024: $16.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,050.56 | 2019-2023 | Kesimpta |
| Abbvie INC. | $643.11 | 2020-2024 | Qulipta, Ubrelvy |
| Genzyme Corporation | $569.79 | 2019-2022 | |
| Amgen INC. | $457.26 | 2020-2022 | |
| Biogen, INC. | $447.88 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $304.26 | 2021 | |
| Allergan, INC. | $213.84 | 2019-2022 | |
| Ucb, INC. | $211.43 | 2020-2021 | |
| Upsher-Smith Laboratories LLC | $179.53 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $154.45 | 2021-2022 | |
| Adamas Pharmaceuticals, INC. | $135.76 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $118.11 | 2021-2022 | |
| Eisai INC. | $115.86 | 2020-2021 | |
| Amneal Pharmaceuticals LLC | $114.13 | 2020-2021 | |
| Lilly USA, LLC | $112.38 | 2020-2021 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $111.52 | 2020-2022 | |
| Celgene Corporation | $105.55 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $101.93 | 2021-2022 | |
| Acorda Therapeutics, INC | $96.20 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $72.93 | 2020-2021 | |
| Neurocrine Biosciences, INC. | $68.78 | 2020-2021 | |
| Horizon Therapeutics Plc | $45.96 | 2021 | |
| Kyowa Kirin, INC. | $45.01 | 2021-2022 | |
| Emd Serono, INC. | $44.60 | 2021 | |
| Acadia Pharmaceuticals INC | $43.61 | 2021 | |
| Aquestive Therapeutics, INC. | $35.49 | 2020-2021 | |
| Livanova USA, INC. | $31.83 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Avanir Pharmaceuticals, INC. | $31.22 | 2021 | |
| Mallinckrodt Hospital Products INC. | $28.25 | 2021 | |
| Dynasplint Systems INC. | $27.58 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.72 | 2022 | |
| Grifols USA, LLC | $25.30 | 2022 | |
| Neurelis, INC. | $20.86 | 2020 | |
| Alexion Pharmaceuticals, INC. | $18.71 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.67 | 2021 | |
| Catalyst Pharmaceuticals, INC. | $14.90 | 2020 | |
| Mdd US Operations, LLC | $14.85 | 2021 | |
| Therapeuticsmd, INC. | $13.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Downey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.